BioHarvest Sciences Inc. Common Stock (BHST)

• Market cap: $97.9M
• 1 day: 4.76%
• 5 days: 15.79%
• 1 month: -1.64%
• 3 months: 21.55%
• 6 months: 14.78%
• Year to date: 7.84%
• 1 year: 14.78%
• 5 years: 14.78%
• 10 years: 14.78%
• Sector: Consumer Staples
• Industry: Packaged Foods

About: BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.

Employees: 87

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

0.51% more ownership

Funds ownership: 0% [Q3] → 0.51% (+0.51%) [Q4]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $14 112% upside
• Avg. target: $14 112% upside
• High target: $14 112% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

HC Wainwright & Co. Amit Dayal 17% 1-year accuracy 20 / 119 met price target

112% upside $14

Buy Reiterated

8 Apr 2025